Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloning

Vaccine

Volumn 27, Issue 2, 2009, Pages 223-233

  Coler, Rhea N ^a   Dillon, Davin C ^b   Skeiky, Yasir A W ^b   Kahn, Maria ^a   Orme, Ian M ^c   Lobet, Yves ^d   Reed, Steven G ^a,b   Alderson, Mark R ^b  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Adjuvants; T lymphocytes; Vaccination

Indexed keywords

ADJUVANT; ADJUVANT AS01B; ADJUVANT AS02A; BCG VACCINE; CULTURE FILTRATE PROTEIN 10; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM VACCINE; RECOMBINANT MTB9.8 ANIGEN; TUBERCULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI; GUINEA PIG; HUMAN; HUMAN CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT RESPONSE; TUBERCULOSIS; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CLONING, MOLECULAR; EPITOPE MAPPING; ESCHERICHIA COLI; GUINEA PIGS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ALIGNMENT; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 57149092786     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.056     Document Type: Article

References (44)

1. World Health Organization. WHO report 2006. Global tuberculosis control: surveillance, planning, financing; 2006.
2. Fine P.E. BCG: the challenge continues. Scandinavian Journal of Infectious Diseases 33 4 (2001) 243-245
3. Muller I., Cobbold S.P., Waldmann H., and Kaufmann S.H. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infection and Immunity 55 9 (1987) 2037-2041
4. Orme I.M. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. Journal of Immunology 138 1 (1987) 293-298
5. Orme I.M., and Collins F.M. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cellular Immunology 84 1 (1984) 113-120
6. Pedrazzini T., Hug K., and Louis J.A. Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guerin in mice. Assessment by elimination of T cell subsets in vivo. Journal of Immunology 139 6 (1987) 2032-2037
7. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., and Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. Journal of Experimental Medicine 178 6 (1993) 2243-2247
8. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. Journal of Experimental Medicine 178 6 (1993) 2249-2254
9. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. New England Journal of Medicine 335 26 (1996) 1956-1961
10. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. New England Journal of Medicine 335 26 (1996) 1941-1949
11. Sorensen A.L., Nagai S., Houen G., Andersen P., and Andersen A.B. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infection and Immunity 63 5 (1995) 1710-1717
12. Coler R.N., Skeiky Y.A., Vedvick T., Bement T., Ovendale P., Campos-Neto A., et al. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. Journal of Immunology 161 5 (1998) 2356-2364
13. Alderson M.R., Bement T., Day C.H., Zhu L., Molesh D., Skeiky Y.A., et al. Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells. Journal of Experimental Medicine 191 3 (2000) 551-560
14. Sanderson S., Campbell D.J., and Shastri N. Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. The Journal of Experimental Medicine 182 December (6) (1995) 1751-1757
15. Koppi T.A., Tough-Bement T., Lewinsohn D.M., Lynch D.H., and Alderson M.R. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. European Journal of Immunology 27 12 (1997) 3161-3165
16. Lewinsohn D.M., Alderson M.R., Briden A.L., Riddell S.R., Reed S.G., and Grabstein K.H. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. Journal of Experimental Medicine 187 10 (1998) 1633-1640
17. Berthet F.X., Rasmussen P.B., Rosenkrands I., Andersen P., and Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low- molecular-mass culture filtrate protein (CFP-10). Microbiology 144 Pt 11 (1998) 3195-3203
18. Colangeli R., Spencer J.S., Bifani P., Williams A., Lyashchenko K., Keen M.A., et al. MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. Infection and Immunity 68 February (2) (2000) 990-993
19. Dillon D.C., Alderson M.R., Day C.H., Lewinsohn D.M., Coler R., Bement T., et al. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infection and Immunity 67 6 (1999) 2941-2950
20. Mettens P., Dubois P.M., Demoitie M.A., Bayat B., Donner M.N., Bourguignon P., et al. Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS, S vaccine antigen. Vaccine 26 February (8) (2008) 1072-1082
21. Skeiky Y.A., Alderson M.R., Ovendale P.J., Guderian J.A., Brandt L., Dillon D.C., et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. Journal of Immunology 172 June (12) (2004) 7618-7628
22. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infection and Immunity 62 6 (1994) 2536-2544
23. Orme I. Protective and memory immunity in mice infected with Mycobacterium tuberculosis. Immunobiology 191 4/5 (1994) 503-508
24. Pal P.G., and Horwitz M.A. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infection and Immunity 60 11 (1992) 4781-4792
25. Mustafa A.S., Shaban F.A., Abal A.T., Al Attiyah R., Wiker H.G., Lundin K.E., et al. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines. Infection and Immunity 68 7 (2000) 3933-3940
26. Roche P.W., Triccas J.A., Avery D.T., Fifis T., Billman-Jacobe H., Britton W.J., et al. T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis. Journal of Infectious Diseases 170 5 (1994) 1326-1330
27. Wilkinson R.J., Wilkinson K.A., De Smet K.A., Haslov K., Pasvol G., Singh M., et al. Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scandinavian Journal of Immunology 48 October (4) (1998) 403-409
28. Horwitz M.A., Lee B.W., Dillon B.J., and Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 92 5 (1995) 1530-1534
29. Hewinson R.G., Michell S.L., Russell W.P., McAdam R.A., and Jacobs Jr. W.R. Molecular characterization of MPT83: a seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70. Scandinavian Journal of Immunology 43 May (5) (1996) 490-499
30. Dillon D.C., Alderson M.R., Day C.H., Bement T., Campos-Neto A., Skeiky Y.A., et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. Journal of Clinical Microbiology 38 September (9) (2000) 3285-3290
31. Skjot R.L., Oettinger T., Rosenkrands I., Ravn P., Brock I., Jacobsen S., et al. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infection and Immunity 68 1 (2000) 214-220
32. Brandt L., Elhay M., Rosenkrands I., Lindblad E.B., and Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infection and Immunity 68 2 (2000) 791-795
33. Brandt L., Oettinger T., Holm A., Andersen A.B., and Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. Journal of Immunology 157 8 (1996) 3527-3533
34. Renshaw P.S., Lightbody K.L., Veverka V., Muskett F.W., Kelly G., Frenkiel T.A., et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. The EMBO Journal 24 July (14) (2005) 2491-2498
35. Guinn K.M., Hickey M.J., Mathur S.K., Zakel K.L., Grotzke J.E., Lewinsohn D.M., et al. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Molecular Microbiology 51 January (2) (2004) 359-370
36. Skjot R.L., Brock I., Arend S.M., Munk M.E., Theisen M., Ottenhoff T.H., et al. Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infection and Immunity 70 October (10) (2002) 5446-5453
37. Renshaw P.S., Panagiotidou P., Whelan A., Gordon S.V., Hewinson R.G., Williamson R.A., et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence. The Journal of Biological Chemistry 277 June (24) (2002) 21598-21603
38. Brandt L., Skeiky Y.A., Alderson M.R., Lobet Y., Dalemans W., Turner O.C., et al. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infection and Immunity 72 November (11) (2004) 6622-6632
39. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine [see comments]. Nature Medicine 2 8 (1996) 893-898
40. Reed S.G., Alderson M.R., Dalemans W., Lobet Y., and Skeiky Y.A. Prospects for a better vaccine against tuberculosis. Tuberculosis (Edinburgh, Scotland) 83 1-3 (2003) 213-219
41. Tsenova L., Harbacheuski R., Moreira A.L., Ellison E., Dalemans W., Alderson M.R., et al. Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis. Infection and Immunity 74 April (4) (2006) 2392-2401
42. van Pinxteren L.A., Cassidy J.P., Smedegaard B.H., Agger E.M., and Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. European Journal of Immunology 30 December (12) (2000) 3689-3698
43. Probst P., Stromberg E., Ghalib H.W., Mozel M., Badaro R., Reed S.G., et al. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. Journal of Immunology 166 January (1) (2001) 498-505
44. Goodall J.C., Yeo G., Huang M., Raggiaschi R., and Gaston J.S. Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library. European Journal of Immunology 31 May (5) (2001) 1513-1522